About the Workshop
Heart disease is the #1 health problem for both women and men in the United States.  Almost 700,000 people die of heart disease in the U.S. each year. That is about 29% of all U.S. deaths.  The risk of coronary heart disease can be reduced by taking steps to prevent and control those adverse factors that put people at greater risk for heart disease and heart attacks. Risk factors that need more attention include diet, nutrition and toxic metal burden from the body.
 
EDTA Chelation therapy involves repeated administration of a synthetic amino acid to reduce atherosclerotic plaque and other toxic mineral deposits throughout the body.  Its use for heart disease is being reviewed at an NCCAM funded multi-center clinical trial. Data on toxic minerals, specifically lead, that contribute to heart disease are published in medical literature on the effect of diet and nutrition on cardiac health.

Your patients have a significant risk of developing heart disease during their lifetime.  With this knowledge, many are becoming interested and self-educated in non-conventional treatment options that will prevent, augment or replace their current pharmacologic regimens.  These patients want to work with a physician that is able to identify their risk for heart disease, recommend preventative nutritional suggestions and feel comfortable implementing a treatment strategy that is effective and safe.

To meet this growing need, this course will provide you with essential information including:

• Practical strategies for incorporating Chelation Therapy for heart disease into your practice and on how to diagnose and treat patients with heavy metal burden
• Tools to evaluate risk factors for developing heart disease
• How to use diet and nutrition to optimize cardiac health

Course Learning Objectives
At the end of the course, participants should be able to:
 
1.     Review current risk factors and methods for testing cardiovascular disease.
2.     Discuss how to apply the various tests for lead and heavy metal exposure.
3.     Understand how to use EDTA chelation therapy safely for heart disease and lead chelation.
4.     Apply the appropriate chelating agent to properly treat heavy metal accumulation.
5.     Gain competence in applying diet and nutrition in the clinical setting to improve cardiac health.
6.     Explain case studies and clinical strategies to identify and treat heart disease.
7.     Apply IV technique for chelation therapy.


Wednesday, November 3, 2010

• 8:00-10:00 am
  Noninvasive Cardiovascular Risk Assessment in Chelation Therapy
  Mark Houston, MD
  
  

• 10:15-12:00 pm
  Mechanisms of Toxic Metals in Coronary Heart Disease and Atherosclerosis
  Mark Houston, MD
  
  
  
• 1:00-2:00 pm
  Integrating Advanced Vascular Risk Factors
  James Biddle, MD
  
  
  
• 2:00-3:00 pm
  Beyond Chelation: IV Therapy with Nutrients
  W. A. Shrader, Jr., MD
  
  
  
• 3:30-4:30 pm
  Advanced Cardiac Imaging with CT and MRI
  Sunil Ram, MD
   
  
  
• 4:30-5:00 pm
  Expert Panel /Q & A
  

Thursday, November 4, 2010

• 8:00-9:00 am
  The Use of EDTA in Clinical Practice
  Jeffrey Morrison, MD
  
  
  
• 9:00-10:00 am
  DMPS and DMSA: Clinical use in Practice
  Jessica Tran, ND
  
  
  
• 10:30-11:30 pm
  Proving Lead Toxicity in a Primary Care Practice
  and Getting Insurance to Pay!
  Dorothy Merritt, MD
  
  
  
• 11:30-12:00 pm
  Case Presentations
  Jeffrey Morrison, MD & Jessica Tran, ND & Dorothy Merritt, MD
  
  
  
• 1:00-2:30 pm
  The Unseen Connection to Cardiovascular Health - Your Mouth! Spread the Word
  Michael Margolis, DDS
  
  
  
• 2:30-3:00 pm
  Legal Update
  Legal Team
  
  
  
• 3:30-4:30 pm
  Glutathione
  Tim Guilford, MD
  
  
  
• 4:30-5:00 pm
  Expert Panel/Q & A
  Jeffrey Morrison, MD & Jessica Tran, ND & Michael Margolis, DDS & Legal Team & Tim Guilford, MD
  
  
  
  *Schedule subject to change without notice
  **Appointments for the CCT Exam on November 4th must be submitted by October 1st, 2010. National Testing Centers are available.